296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 259 institutions

RCOphth Annual Congress 2026

18 - 21 May, 2026 | Manchester Central, Manchester

Topics

Showing 79 results.

Thumbnail for Second- to fifth-line switching to Eylea 8mg for neovascular age-related macular degeneration and diabetic macular oedema: Real-world outcomes from a single centre.

P193

Second- to fifth-line switching to Eylea 8mg for neovascular age-related macular degeneration and diabetic macular oedema: Real-world outcomes from a single centre.

Miranda Buckle, Shaswath Ganapathi, Quresh Mohamed, Salman Asghar, Vidya Pulpa, Kate Hellier

Poster Presenter: Miranda Buckle

Thumbnail for Service Evaluation of the Prevalence of Hydroxychloroquine Retinopathy using the 2020 Royal College of Ophthalmologists Revised Diagnostic Criteria

P194

Service Evaluation of the Prevalence of Hydroxychloroquine Retinopathy using the 2020 Royal College of Ophthalmologists Revised Diagnostic Criteria

Michele Chan, Nigel Davies

Poster Presenter: Michele Chan

Audio

P195

Sickle Cell Retinopathy Gradings and Progression during Pregnancy

Callum Singh Grewal, Peck-Lin Lip

Poster Presenter: Callum Singh Grewal

P196

SPECTRUM UK cohort analysis: Early real-world outcomes with aflibercept 8 mg in patients with nAMD

Manju Chandran

Poster Presenter: Manju Chandran

Thumbnail for SPECTRUM: Latest clinical data from the first global real-world study of aflibercept 8 mg in patients with treatment-na?ve and previously treated DME

P197

SPECTRUM: Latest clinical data from the first global real-world study of aflibercept 8 mg in patients with treatment-na?ve and previously treated DME

Nirodhini Narendran

Poster Presenter: Nirodhini Narendran

P198

SPECTRUM: Latest clinical data from the first global real-world study of aflibercept 8 mg in patients with treatment-na?ve and previously treated nAMD

Vasileios Konidaris

null

Poster Presenter: Vasileios Konidaris

Thumbnail for Structural Insights into Avacincaptad Pegol Inhibition of C5 Activation for the Treatment of Geographic Atrophy Secondary to Age-related Macular Degeneration

P199

Structural Insights into Avacincaptad Pegol Inhibition of C5 Activation for the Treatment of Geographic Atrophy Secondary to Age-related Macular Degeneration

Christiana Dinah, Ganeswara Rao Musada, Laura Moreno-Leon, Arina Afanaseva, Nicole Lombardi, Nicolas Lonfat, Kenichi Mori, Sharon Bakalash, Hemant Khanna

Ophthalmology Department, London North West University Healthcare NHS Trust, Harrow, UK, Formerly Astellas Pharma Inc., Astellas Pharma Inc., Westborough, MA, USA, Astellas Pharma Inc., Tokyo, Japan

Poster Presenter: Christiana Dinah

Thumbnail for Structure-Function Link of Ellipsoid Zone Integrity and Low Luminance Deficit in Avacincaptad Pegol-Treated Eyes with Geographic Atrophy

P200

Structure-Function Link of Ellipsoid Zone Integrity and Low Luminance Deficit in Avacincaptad Pegol-Treated Eyes with Geographic Atrophy

Richard Gale, Rachel Downes, Karen Matar, Reem Amine, Asmita Indurkar, Amy Tang, Lyndsey DellaVecchia, John Mamone, Katherine E. Talcott, Janet Kim, Don Luo, Olga Cerόn, Dina Abulon, Justis...

University of York and York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA, The Tony and Leona Campane Center for Excellence in Image...

Poster Presenter: Richard Gale

Thumbnail for The diagnostic accuracy of diabetic retinopathy screening using hand-held retinal imaging devices in real-world settings: a systematic review and meta-analysis.

P201

The diagnostic accuracy of diabetic retinopathy screening using hand-held retinal imaging devices in real-world settings: a systematic review and meta-analysis.

Charith Mayadunne, Mapa Piyasena

School of Medicine, Anglia Ruskin University, Chelmsford, Vision and Eye Research Institute, Anglia Ruskin University, Cambridge

Poster Presenter: Charith Mayadunne